Ursolic acid is compound (a type of pentacyclic triterpene) that forms part of the waxy coating of fruits such as apples and cranberries. Ursolic acid has been shown to inhibit tumor formation and growth of (hormone receptor positive (ER+/PR+), HER2 overexpressing (HER2+) and triple negative (ER-/PR-/HER2-) breast cancer.
Ursolic acid reverses multidrug resistance
Ursolic acid has been shown to reverse multidrug resistance in breast cancer cells. One study reported that ursolic acid resensitized cisplatin-resistant liver cancer cells to cisplatin chemotherapy. Another study found that ursolic acid reversed resistance to Taxol (paclitaxel) in Taxol-resistant triple negative breast cancer. Still another study demonstrated that ursolic acid resensitized multidrug resistant ER+/PR+ breast cancer cells to Adriamycin (doxorubicin) chemotherapy. Now a new preprint (a study that has not completed formal peer review and publication) has reported that ursolic acid also sensitizes Adriamycin-resistant triple negative breast cancer cells to Adriamycin.
Foods high in ursolic acid
As noted above, ursolic acid is found in the waxy coating of the peels of apples of all varieties. Apple peels are the most abundant dietary source of this compound. However, note that conventionally grown apples typically are produced using relatively high levels of pesticides. Such apples normally are washed after picking, which removes some of the pesticide residue, but also strips off some of the waxy cuticle. Food grade wax is then applied to the apples, which can seal in some of the remaining pesticide residue. Therefore, organically grown apples are best.
Ursolic acid is also present in the peels of a variety of other chemopreventive fruits, as well as some culinary herbs:
Sage is also a source of ursolic acid, but we do not recommend it for breast cancer patients and survivors.
Latest research shows ursolic acid potentiates Adriamycin
The study referenced above was designed to investigate whether ursolic acid can affect the resistance of triple negative breast cancer cells to Adriamycin. To conduct the study, the authors assessed the viability, proliferation, and apoptosis (programmed cell death) of Adriamycin-resistant triple negative breast cancer cells with and without treatment with ursolic acid.
Ursolic acid was found to reduce the growth, and alleviate resistance to Adriamycin, of two Adriamycin-resistant triple negative breast cancer cell lines. The authors demonstrated that multidrug resistance-associated protein 1 (ABCC1) expression was downregulated by ursolic acid. As a result, ursolic acid abrogated the malignant phenotypes of Adriamycin-resistant triple negative breast cancer cells. The authors conclude that ursolic acid increases sensitivity of triple negative breast cancer cells to Adriamycin by inactivating ZEB1-AS1/miR-186-5p/ABCC1 signaling.
Please see our articles on foods to eat and avoid for triple negative patients and those on Adriamycin for more information.